Both of these clones recognize the wild-type peptide (EAAGIGILTV) and the commonly used heteroclitic version (ELAGIGILTV) (40) of the melan A/MART1 peptide (Fig. 6B, middle panels) and kill autologous tumor (Fig. 6B, right panels). This evidence concerns the gene MLANA and neoplasm.